Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FSHR | P23945 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 2/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1420964 | 0.87 | BACE1 (0.39) | AAK1BACE1BRAF | |
| SCHEMBL1421089 | 0.85 | BRAF (0.33) | AAK1LCKBACE1BRAFCYP17A1 | |
| SCHEMBL1420877 | 0.83 | BACE1 (0.43) | TSHRFSHRBACE1CYP17A1 | |
| SCHEMBL1420827 | 0.82 | BACE1 (0.35) | AAK1LCKBACE1BRAF | |
| SCHEMBL3191088 | 0.78 | BACE1 (0.40) | BACE1 | |
| SCHEMBL3191096 | 0.78 | BACE1 (0.40) | BACE1 | |
| SCHEMBL932781 | 0.75 | BACE1 (0.32) | AAK1BACE1 | |
| SCHEMBL13533306 | 0.74 | BACE1 (0.40) | AAK1LCKBACE1BRAF | |
| SCHEMBL1420822 | 0.71 | ACVR1B (0.36) | BACE1BRAFCYP17A1 | |
| SCHEMBL1441066 | 0.71 | BACE1 (0.35) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297120-A1 | AMINODIHYDROTHIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Eli Lilly & Company (US) | 2011-03-23 | — | — | EP | disclosed |
| WO-2009134617-A1 | AMINODIHYDROTHIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 2009-11-05 | — | — | WO | disclosed |